Paper · 29414248

Epithelial Mesenchymal Transition in Tumor Metastasis.

Mittal V. Annu Rev Pathol, 2018. Cited by 1,231 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Epithelial Mesenchymal Transition in Tumor Metastasis. Papers, record 29414248. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29414248

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Epithelial Mesenchymal Transition in Tumor Metastasis.; PubMed
Journal: Annu Rev Pathol; PubMed
Year: 2018; PubMed
Publication types: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/29414248/; PubMed
DOI: https://doi.org/10.1146/annurev-pathol-020117-043854; PubMed
The journal: https://conductscience.org/library/journal-index/101275111; PubMed
Citations, by iCite: 1,231; iCite
Relative citation ratio, by iCite: 47.5; iCite
Revised in PubMed: 2022-04-09; PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Mittal V	Vivek

Source PubMed

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Epithelial-Mesenchymal Transition	Major topic
Neoplasm Invasiveness	Major topic
Neoplasms	Major topic
Humans

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

Trial	Title	The trial lists it as	Named in the paper's record
NCT04239105	Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device	Background

Source ClinicalTrials.gov

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by900

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,231 citations.

PMID	Title	Journal	Year	In Papers	Source
42,902,326	Cancer metastasis: biological mechanisms, therapeutic bottlenecks, and emerging interventions.	J Hematol Oncol	2026	https://conductscience.org/library/papers/42902326	PubMed
42,876,538	Streptococcus anginosus extracellular vesicles deliver protein to promote gastric cancer progression.	Front Cell Infect Microbiol	2026	https://conductscience.org/library/papers/42876538	PubMed
42,807,213	Exosomes from Cancer-associated Fibroblasts Orchestrate Lung Metastasis of Breast Cancer via LncRNA LMAEP.	J Cancer	2026	https://conductscience.org/library/papers/42807213	PubMed
42,797,419	Anticancer Effects of Fluphenazine Alone and in Combination with Cisplatin in Gastric Cancer Cells and a Mouse Xenograft Model.	Pharmaceuticals (Basel)	2026	https://conductscience.org/library/papers/42797419	PubMed
42,786,155	Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma.	Nat Commun	2026	https://conductscience.org/library/papers/42786155	PubMed
42,744,036	Therapeutic potential of colchicine-binding site inhibitors in breast cancer brain metastasis.	Cancer Lett	2026	https://conductscience.org/library/papers/42744036	PubMed
42,704,707	Distinct molecular profiles of indeterminate and malignant thyroid nodules in patients under 21 years of age.	Endocr Relat Cancer	2026	https://conductscience.org/library/papers/42704707	PubMed
42,699,228	Tissue-derived extracellular matrix hydrogels instruct epigenetic adaptation in metastatic colonization.	Bioact Mater	2027	https://conductscience.org/library/papers/42699228	PubMed
42,669,662	PI3K/AKT signaling pathway: molecular crossroads in tumorigenesis and therapeutic innovation.	Signal Transduct Target Ther	2026	https://conductscience.org/library/papers/42669662	PubMed
42,662,548	Discovery of Bis-Thiourea Derivatives as Human DNA Topoisomerase IIα Inhibitors with Potent Anticancer Effects.	ACS Omega	2026	https://conductscience.org/library/papers/42662548	PubMed

1 to 10 of 900

See all 900 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29414248

GET https://conductscience.org/api/papers/v1/29414248/cited_by?page=2

API reference For AI assistants